Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of tanezumab for pain associated with chronic abacterial prostatitis
2008-004861-25Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic prostatitis (CP) comparing Tanezumab with Placebo (2 arms). Primary endpoint: Change in average daily pain from baseline to week 6. Started Dec 2008; status: completed.
02
Drugs
tanezumab
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on 2008-004861-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004861-25.